规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | BAY-1797 is a potent, orally bioavailable, and selective antagonist of P2X4, exhibiting an IC50 of 211 nM against human P2X4. It has little to no activity on other P2X ion channels. BAY-1797 demonstrates anti-nociceptive and anti-inflammatory properties[1]. |
Animal study | BAY-1797 (12.5-50 mg/kg; pO.) significantly increases PGE2 levels in the inflamed paw within the mouse Complete Freund’s Adjuvant (CFA) inflammatory pain model[1].BAY-1797 (50 mg/kg; once daily for multiple pO. administrations) significantly lowers the load on the ipsilateral paw 24 and 48 hours post Complete Freund’s Adjuvant (CFA) injection[1].Under BAY-1797 treatment, the normalized area under the curve (AUCnorm), steady-state volume of distribution (Vss), and half-life (t1/2) are reported as 1.06 kg h/L, 3.67 L/kg, and 2.64 hours, respectively[1]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.40mL 0.48mL 0.24mL |
11.99mL 2.40mL 1.20mL |
23.99mL 4.80mL 2.40mL |
CAS号 | 2055602-83-8 |
分子式 | C20H17ClN2O4S |
分子量 | 416.88 |
SMILES Code | O=C(NC1=CC=C(OC2=CC=CC(Cl)=C2)C(S(=O)(N)=O)=C1)CC3=CC=CC=C3 |
MDL No. | MFCD32689580 |
别名 | |
运输 | 蓝冰 |
InChI Key | CSJYMAFXYMYNCK-UHFFFAOYSA-N |
Pubchem ID | 124125214 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place, sealed in dry, room temperature |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|